“…The specificities of the primary antibodies JIM5 and JIM7 (CarboSource) have been extensively described (Liners et al, 1989;Knox et al, 1990;Knox, 1997;Willats et al, 2001aWillats et al, , 2001bWillats et al, , 2001cMacquet et al, 2007a;Pattathil et al, 2010;Xu et al, 2011). JIM13, MAC207, JIM8, and CCRC-M7 (CarboSource) have also been previously described (Bradley et al, 1988;Pennell et al, 1989Pennell et al, , 1991Knox et al, 1991;Puhlmann et al, 1994;Yates and Knox, 1994;Steffan et al, 1995;Yates et al, 1996;Majewska-Sawka and Nothnagel, 2000;Pattathil et al, 2010). CBM3a, specific to more crystalline cellulose, and CBM28, specific to more amorphous cellulose regions (Blake et al, 2006), were treated as primary antibodies in identical solutions before treatment with mouse anti-histidine (Qiagen).…”